Exercise and Cognitive Help for Older Cancer Survivors

Exercise and Cognitive Rehab in Older Cancer Survivors

Recruiting N/A Interventional Study
Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
60 and older
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
40 (estimated)
Sponsor
University of Rochester · Other
Who this trial is looking for

This trial is looking for older cancer survivors who are concerned about their memory or thinking skills after treatment. Participants will take part in a program that combines exercise and cognitive help.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am 60 years old or older
  • I have been diagnosed with any type of cancer
  • I have completed treatment aimed at curing my cancer
  • I am concerned about my memory or thinking abilities after treatment
  • I speak English
  • I can walk 4 meters
  • I am able to provide informed consent

You may not be able to join if

  • I have physical, psychological, or social problems that would prevent me from joining the study

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

The objective of the study is to evaluate the feasibility of a combined mobile health exercise and cognitive rehabilitation intervention and its effect on cognition in a single-arm pilot study that recruits cancer survivors.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age ≥60 years at the time of consent * Have a diagnosis of any cancer * Have completed curative intent treatments * Patients on endocrine therapies are allowed to enroll * Patients with hematologic malignancies after autologous or allogeneic stem cell transplant are allow…
Contacts

Kah Poh Loh

585-276-4353

Kahpoh_Loh@URMC.Rochester.edu

CONTACT

Becky Gravenstede

585-727-4728

becky_gravenstede@urmc.rochester.edu

CONTACT